Jennifer J. Oh

Pharmacokinetics and Pharmacodynamics of a Bolus and Infusion of Cangrelor: A Direct, Parenteral P2Y12 Receptor Antagonist

Wendell S. Akers, Jennifer J. Oh, Julie H. Oestreich et al. · The Journal of Clinical Pharmacology · 2009 · 168 citations

Thrombopoiesis, Thrombosis, Pharmacological Study +13

Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect

Steven R. Steinhubl, Jennifer J. Oh, Julie H. Oestreich et al. · Thrombosis Research · 2007 · 165 citations

Pharmacology, Clinical Pharmacology, Competitive Effect +4

Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles

Joanna Koziara, Jennifer J. Oh, Wendell S. Akers et al. · Pharmaceutical Research · 2005 · 123 citations

Nanoparticles, Nanomedicine, Engineering +4

Recombinant Factor VIIa for Refractory Bleeding After Cardiac Surgery Secondary to Anticoagulation with the Direct Thrombin Inhibitor Lepirudin

Jennifer J. Oh, Wendell S. Akers, Daniel A. Lewis et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2006 · 54 citations

Heart Failure, Adult Cardiac Surgery, Refractory Bleeding +21

Continuous versus Intermittent Infusion of Prophylactic Cefoxitin After Colorectal Surgery: A Pilot Study

Terri J. Suffoletta, Heath R Jennings, Jennifer J. Oh et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2008 · 13 citations